Purchases and Sales Made in Q3 2023 in In Med Pharmaceuticals Inc. (INM)
This table provides information about the institutional ownership of In Med Pharmaceuticals Inc. (INM) during Q3 2023. The information is specifically focused on institutions that hold shares of InMed Pharmaceuticals Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
12.9K+ 94.48% |
$8.91K - $15.8K
|
26.6K
$6.38K
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
BUY
|
- |
69New |
$47.6 - $84.2
|
69
$16.6
|
|
Nov 13, 2023
Q3 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
19+ 45.24% |
$13.1 - $23.2
|
61
$14.6
|
|
Oct 10, 2023
Q3 2023
|
National Bank Of Canada
|
BUY
|
- |
8+ 66.67% |
$5.52 - $9.76
|
20
$4.8
|
|
Nov 14, 2023
Q3 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
8+ 44.44% |
$5.52 - $9.76
|
26
$6.24
|
|
Nov 02, 2023
Q3 2023
|
Gables Capital Management Inc.
|
BUY
|
- |
1New |
$0.69 - $1.22
|
1
$0.24
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|